Profit before interest, taxes and amortization: Annovis Bio Inc (ANVS)
Betting on the expansion of braintap in the treatment of Alzheimer's and Parkinson's, Annovis Bio, Inc. (ANVS) is striving for a market breakthrough. EBITDA in monetary terms demonstrates profit dynamics, where the value of 0.00 corresponds to the current metric. However, the lack of stable sales and reliance on external financing create risks. The absence of mature products confirms that business momentum is based exclusively on research potential.
Annovis Bio Corp - analytical breakdowns and key metrics (ANVS)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- company total debt and liquidity indicators:
Total Debt to Capital Coefficient Annovis Bio, Inc.|ANVS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Annovis Bio Corp|ANVS - Company Aggregate Debts|Debt to Book Capitalization Ratio Annovis Bio, Inc.|ANVS - Company Long-Term Debts|Short-Term Debt Volume Annovis Bio|Immediate Liquidity annovisbio.com
- net income and valuation multiples indicators:
ANVS - Net Income|Expected Net Income Annovis Bio, Inc.|ANVS - P/E Multiple|Market Cap to Projected Earnings Annovis Bio Inc|ANVS - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Annovis Bio, Inc.|ANVS - Operating profit EBITDA|Net earnings per share for the last 12 months Annovis Bio|ANVS - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months annovisbio.com|ANVS - Earnings growth in current year|Earnings growth forecast for next year Annovis Bio, Inc.
- sales revenue and business income indicators:
Summary company analytics:Annovis Bio, Inc. (ANVS)
For Annovis Bio, Inc. (ANVS), whose operations focus on clinical trials and strictly regulated waste disposal, operational efficiency takes on a specific character. The EBITDA_Co metric captures daily cash flow from core operations excluding depreciation, allowing investors to use this chart's price action to promptly identify business process stagnation or, conversely, confirm an influx of institutional capital into the asset.
Who Annovis Bio, Inc. competes with
Biogen Inc. (BIIB) - Profit before interest, taxes and amortization|NBIX - Profit before payment of interest, taxes and amortization|RGC (Regencell Bioscience Holdings Limited) - Operating profit before amortization|Axsome Corp (AXSM) - Profit before payment of interest, taxes and amortization|ACAD - Operating income before deduction of amortization|Operating profit before deduction of amortization XENE|VKTX - Operating profit before depreciation charges|Operating profit before deduction of amortization SUPN (supernus.com)|Operating income before deduction of amortization Catalyst Pharmaceuticals Inc|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AMLX (Amylyx Pharmaceuticals)|Trevi Therapeutics, Inc. (TRVI) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Praxis Precision Medicines, Inc. (PRAX)|AVXL (anavex.com) - Operating profit EBITDA|Operating profit before amortization CBLL (CeriBell Corp)|Profit before payment of interest, taxes and amortization Prothena Biosciences (PRTA)|Operating income before deduction of amortization Alector|Operating profit EBITDA ANNX (annexonbio.com)|Income before deduction of interest, taxes and amortization OMER|NGNE: Operating profit before deduction of amortization|ACIU (AC Immune Corp) - Operating profit before amortization|VYGR: Operating profit EBITDA|Profit before interest, taxes and amortization Neumora Therapeutics, Inc. (NMRA)|SCLX (Scilex Holding) - Operating profit EBITDA|Operating profit before amortization TVGN (Tevogen Bio)|Operating profit EBITDA ACOG|CGTX - Profit before interest, taxes and amortization|Inhibikase Pharma - Operating profit before deduction of amortization|Operating income before deduction of amortization cassavasciences.com (SAVA)|Assertio Holdings - Operating profit EBITDA|Operating income before deduction of amortization Coya Therapeutics COYA|VTGN: Operating profit EBITDA|Operating profit before amortization OVID|Profit before payment of interest, taxes and amortization Acumen Pharmaceuticals|CRVO: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ATHE|CLNN - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization PepGen Inc PEPG|Operating income before deduction of amortization jupiterneurosciences.com (JUNS)|Relmada Therapeutics, Inc. - Operating profit EBITDA|Operating profit before depreciation charges Grace Therapeutics (GRCE)|AIFF: Operating profit EBITDA|ANEW Medical, Inc. (KLTO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd.|RVPH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MTVA|Operating profit EBITDA NeurAxis (NRXS)|Helius Medical Technologies, Inc. - Operating profit before deduction of amortization|Operating income before deduction of amortization Passage Bio, Inc. (PASG)|Neuphoria - Operating profit EBITDA|Income before deduction of interest, taxes and amortization NERV (Minerva)|ATHA: Operating profit EBITDA|Operating profit before amortization ADXN|Operating profit before deduction of amortization ALZN|Profit before interest, taxes and amortization Cyclerion Therapeutics CYCN|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|Operating profit EBITDA Pasithea Therapeutics Corp (KTTA)|Cortigent, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Avenue Therapeutics ATXI|BCLI - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization CARA (Cara Therapeutics)|Chromocell Therapeutics Corporation (CHRO) - Profit before payment of interest, taxes and amortization|Eliem Therapeutics, Inc. - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization ITCI|Profit before interest, taxes and amortization longboardpharma.com LBPH|Profit before payment of interest, taxes and amortization Marinus (MRNS)|Company profit before taxes, interest and amortization NKGN|Operating profit EBITDA NRBO (NeuroBo)|Income before deduction of interest, taxes and amortization SAGE|SNPX: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Trevena|VIGL: Operating profit EBITDA|WENA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Cerevel
